PURPOSE:This study aimed to evaluate the serum levels of thrombospondin-1, growth differentiation factor-15, resolvin D1, and resolvin E1 in patients with keratoconus. METHODS:Thirty-five patients with keratoconus and 35 control subjects of similar age and sex were evaluated. The keratoconus group was divided into four stages according to the modified Krumeich classification. Commercial kits were used to determine thrombospondin-1, growth differentiation factor-15, resolvin D1, and resolvin E1 levels in serum samples using enzyme-linked immunosorbent assay (ELISA). Serum thrombospondin-1, growth differentiation factor-15, resolvin D1, and resolvin E1 levels were compared between the patient and control groups. RESULTS:The keratoconus group consisted of 14 females and 21 males, and the control group consisted of 14 females and 21 males, with mean ages of 29.4±8.8 and 30.0±7.8 yr, respectively. There were significant differences in serum thrombospondin-1, growth differentiation factor-15, resolvin D1, and resolvin E1 levels between the serum of the keratoconus and control groups (p=0.006, p<0.001, p<0.001, and p=0.001, respectively). No significant correlations were found between keratoconus stage and serum thrombospondin-1, growth differentiation factor-15, resolvin D1 and resolvin E1 levels (r=-0.025, p=0.892; r=-0.019, p=0.913; r=-0.036, p=0.838; and r=-0.108, p=0.538, respectively). CONCLUSION:Serum levels of thrombospondin-1, growth differentiation factor-15, resolvin D1, and resolvin E1 were significantly lower in patients with keratoconus. These results suggest that these parameters may be associated with the pathogenesis of keratoconus.
Purpose: This study aimed to evaluate the agreement between the internal astigmatism axis obtained using the optical path difference-Scan III (NIDEK Co., Japan) and conventional slit-lamp biomicroscopic measurements for determining the toric intraocular lens axis in non-dilated eyes. Methods: This retrospective study included 56 eyes that underwent toric intraocular lens implantation and were evaluated at postoperative week 6. The toric intraocular lens axis was measured using the optical path difference-derived internal astigmatism axis under mesopic conditions without pharmacologic pupil dilation and compared with slit-lamp biomicroscopic measurements obtained after pharmacologic dilation. Agreement between the two methods was assessed using Bland-Altman analysis, the intraclass correlation coefficient, angular error analysis, and the distribution of clinically relevant deviations. Subgroup analyses were performed for plate-haptic and C-loop haptic intraocular lens. Results: The mean signed angular difference between the two methods was 0.00° (95% CI:, -0.41° to +0.41°), with 95% limits of agreement ranging from -2.99° to +2.99°. No systematic or proportional bias was observed. The mean absolute angular error was 1.21°±0.91°, and no eye demonstrated an intermethod discrepancy exceeding 5°. The difference between the two methods was ≤1° in 73.2% of eyes, ≤3° in 98.2%, and ≤5° in all eyes. Excellent agreement was observed between the two techniques (intraclass correlation coefficient >0.99, p<0.001). Comparable agreement was also observed in both the plate-haptic and C-loop haptic intraocular lens subgroups. Conclusions: Optical path difference-derived internal astigmatism axis measurements demonstrated excellent agreement with conventional slit-lamp biomicroscopic assessment for postoperative evaluation of toric intraocular lens alignment. The low angular error, narrow limits of agreement, and absence of clinically meaningful discrepancies suggest that this technique may serve as a reliable alternative for determining the toric intraocular lens axis in non-dilated eyes with adequate pupil size.
Corneal blindness affects more than 12 million individuals worldwide; however, the availability of human donor corneas meets only a small fraction of the demand. Porcine corneal xenotransplantation represents a promising alternative because of the cornea’s immune privilege and the anatomical similarities between human and porcine corneas. However, the galactose-α1,3-galactose antigen expressed on porcine cells induces hyperacute rejection through the activation of human anti-Gal antibodies, complement pathways, and innate immune cell infiltration. This review summarizes the mechanisms underlying corneal immune privilege and contrasts them with galactose-α1,3-galactose-mediated rejection pathways. In addition, it evaluates five major mitigation strategies: GGTA1-knockout pigs, enzymatic α-galactosidase treatment, RNA interference, decellularization, and immunosuppressive approaches, including CD40-CD154 blockade and topical tacrolimus. Preclinical studies have demonstrated that GTKO corneas can maintain transparency for longer than 1 year, whereas decellularized matrices preserve corneal architecture while exhibiting low antigenicity. These findings support the future clinical translation of porcine corneal xenotransplantation.
Purpose: To determine the indications and epidemiological characteristics of corneal transplant recipients at a referral center in Amazonas, Brazil, and to evaluate postoperative visual outcomes. Methods: This retrospective, descriptive, observational study included adult patients who underwent corneal transplantation performed by a single surgeon at the Instituto de Oftalmologia de Manaus between 2013 and 2023. Demographic characteristics, occupation, comorbidities, surgical indications, graft type, and best-corrected visual acuity at baseline and 12 months postoperatively were analyzed. Results: A total of 413 corneal transplantations were performed, predominantly in male patients (64.4%) aged 41-70 years (43.3%). Leucoma was the most common indication (26.2%), followed by perforated corneal ulcers (21.1%), bullous keratopathy (17.9%), and keratoconus (10.7%). Penetrating keratoplasty accounted for 94.9% of all procedures. Optical keratoplasty was the most frequently performed procedure (76.3%), followed by tectonic (22.0%) and therapeutic (1.7%) keratoplasty. At 12 months postoperatively, visual improvement was greatest among patients who underwent optical keratoplasty, particularly those with keratoconus, bullous keratopathy, and leucoma. Functional vision (≤0.3 logMAR) was achieved in 32.6% of eyes overall and in 40.3% of eyes that underwent optical keratoplasty. The number of transplantations declined after 2019, coinciding with the COVID-19 pandemic. Conclusions: This study represents the largest retrospective series of corneal transplantations in Amazonas and one of the few such studies from Northern Brazil. The predominance of leucoma and infectious corneal perforation reflects regional socioeconomic and occupational vulnerabilities. Although visual outcomes improved significantly after transplantation, visual recovery was limited by the advanced stage of disease at presentation. These findings underscore the need to expand access to early diagnosis, strengthen eye banking and donor tissue procurement systems, and increase the adoption of lamellar keratoplasty techniques to optimize visual outcomes in the Amazon region.
Purpose: Neuro-ophthalmology is a highly specialized subspecialty at the interface of neurology and ophthalmology. Globally, workforce shortages and geographic maldistribution limit access to neuro- -ophthalmic care. Although Brazil has a large ophthalmology workforce, regional disparities may restrict access to subspecialty services. The national distribution of neuro-ophthalmologists has not previously been quantified. This study aimed to characterize the geographic distribution of neuro-ophthalmologists in Brazil and identify potential gaps in access to neuro-ophthalmic care. Methods: This cross-sectional, population-based study used data from the registry of the Brazilian Neuro-Ophthalmology Association (Associação Brasileira de Neuro-Oftalmologia [ABNO]) to identify practicing neuro-ophthalmologists (data extracted on January 1, 2026). Municipal- and state-level population estimates were obtained from the Brazilian Institute of Geography and Statistics. Specialist density was calculated as the number of neuro-ophthalmologists per million inhabitants. States were classified according to the presence or absence of at least one specialist and were further grouped into Brazil’s five macroregions for comparative analyses. Descriptive statistical analyses were performed. Results: A total of 66 neuro- -ophthalmologists were identified across 14 of Brazil’s 27 states. Thirteen states had no registered neuro- -ophthalmologists, representing approximately 49.4 million people (23.2% of the national population). Five states—São Paulo (n=31), Rio de Janeiro (n=6), Minas Gerais (n=6), Pernambuco (n=4), and Paraná (n=4)—accounted for more than two-thirds of all specialists. Specialist density ranged from 0 to more than 0.7 per million inhabitants, with higher concentrations in the Southeast and no specialists in several states in the North and Northeast. The distribution was highly clustered in metropolitan areas. Conclusion: Brazil exhibits marked geographic maldistribution of neuro-ophthalmologists, with nearly one-quarter of the population lacking local access to specialized care. The concentration of specialists in urban and economically developed regions mirrors international trends and may exacerbate inequities within the public health system. Expanding the workforce and integrating teleophthalmology into neuro-ophthalmic services may help reduce regional disparities and improve access to specialized care.
Purpose: To evaluate the efficacy of autologous fat grafting for treating enophthalmos in anophthalmic sockets. Methods: In this prospective interventional case series, consecutive patients with anophthalmic sockets and enophthalmos were enrolled between August 2013 and July 2025. Clinical ophthalmologic examination, Hertel exophthalmometry, and orbital computed tomography scans were performed. Enophthalmos was assessed clinically and radiologically before and after orbital lipofilling with autologous fat. Fat was harvested from the inner thigh and injected into the inferolateral orbital compartment. The volume of injected fat was determined according to the degree of enophthalmos measured by Hertel exophthalmometry. Follow-up ranged from 2 to 60 months (median, 7 months). Results: Thirteen patients (13 sockets) underwent orbital autologous fat grafting using Coleman’s technique. The injected fat volume ranged from 3.7 to 6 mL per procedure (median, 4.2 mL). Clinically, a reduction in enophthalmos of 1-5 mm was observed in 12 cases (median, 2 mm), which was associated with a decrease in prosthesis thickness. One patient developed a fat cyst due to anterior fat migration, and three patients required repeat grafting because of undercorrection. Computed tomography scans, available for nine patients, demonstrated a 6.8%-10.8% increase in intraorbital volume, particularly in the inferolateral quadrant. Conclusions: Clinical and radiological assessments demonstrated that lipofilling is an effective technique for restoring orbital volume in anophthalmic sockets with enophthalmos.
Purpose: To compare clinical outcomes associated with different intraoperative mitomycin C exposure times during photorefractive keratectomy for myopia and astigmatism correction. Methods: This prospective, comparative, contralateral-eye study included 41 patients (82 eyes), comprising 28 eyes with ablation <60μm and 13 eyes with ablation >60μm, who underwent photorefractive keratectomy with varying mitomycin C application times based on ablation depth. In eyes with ablation <60μm, mitomycin C was applied for 15 s in one eye and 30 s in the fellow eye. In eyes with ablation >60μm, mitomycin C was applied for 30 s in one eye and 60 s in the fellow eye. Outcomes included visual acuity, postoperative pain (visual analog scale), subjective tearing, corneal haze, and refractive results at 3 months. Results: No statistically significant differences were observed between mitomycin C application times within either group for postoperative pain, tearing, visual acuity, refractive outcomes (spherical, cylindrical, and spherical equivalent), or haze prevalence (p>0.05 for all comparisons). Visual acuity improved in all groups, and no eyes lost ≥2 lines of corrected distance visual acuity. Conclusions: Shorter mitomycin C exposure times (15 or 30 s) appear to be as effective and safe as longer durations (30 or 60 s) for haze prevention after photorefractive keratectomy without compromising refractive outcomes or increasing postoperative discomfort at 3-month follow-up.
This systematic review and meta-analysis aimed to compare the effectiveness and safety profiles of anti-vascular endothelial growth factor therapy with dexamethasone vs anti-vascular endothelial growth factor alone in patients with persistent diabetic macular edema. It was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. Our data were prospectively registered on the International Prospective Register of Systematic Reviews (CRD42023482385). We searched the PubMed, Embase, Cochrane, and Web of Science databases for studies that compared treatment with anti-vascular endothelial growth factor and dexamethasone to anti-vascular endothelial growth factor alone in patients with persistent diabetic macular edema. The primary outcomes were changes in best corrected visual acuity, changes in central macular thickness, and the incidence of serious adverse events. Four studies were included, totaling 315 eyes. Of these 154 (48.88%) received anti-vascular endothelial growth factor alone, while 161 (51.12%) underwent combined therapy. Overall, combined therapy was associated with better central macular thickness (mean difference -68.21; p<0.001), although this did not translate into a significant difference in best-corrected visual acuity at 1 month follow-up (mean difference 1.29; p=0.55). There were significantly more intraocular pressure-related events (odds ratio 10.84; p=0.02) and cataract-related events (odds ratio 41.24; p<0.001) in the combined group than the anti--vascular endothelial growth factor alone group. Our results suggest that combined therapy improves macular morphology in persistent diabetic macular edema without increasing the risk of serious adverse events. However, its effects on final visual acuity outcomes were no better than those resulting from anti-vascular endothelial growth factor therapy alone.
Purpose: To compare the impact of pro re nata and treat-and-extend regimens on quality of life in patients with neovascular age-related macular degeneration. Methods: This cross-sectional study included 81 patients with neovascular age-related macular degeneration who completed the National Eye Institute Visual Function Questionnaire-25. Results: No statistically significant differences were observed between pro re nata and treat-and-extend regimens across quality-of-life domains measured by National Eye Institute Visual Function Questionnaire-25. Conclusions: Pro re nata and treat-and-extend regimens demonstrated comparable effects on quality of life in patients with neovascular age-related macular degeneration. Further studies are warranted to determine optimal standardized treatment strategies.
Purpose: To assess the performance of a contemporary large language model (ChatGPT-5) against ophthalmology residents on a standardized set of glaucoma multiple-choice questions. Methods: We conducted a cross-sectional comparative study with 189 text-only glaucoma multiple-choice questions from the Cybersight question bank. ChatGPT-5 was tested under standardized conditions, with each item placed in a new chat and limited to letter-only outputs. Six ophthalmology residents from a Brazilian training program (two Postgraduate Year 1, two Postgraduate Year 2, and two Postgraduate Year 3) answered the same questions under supervision. Accuracy was calculated using the official key. McNemar’s exact test was used to compare items between ChatGPT-5 and residents, and matched odds ratios and 95% confidence intervals (95% CIs) were calculated using the Haldane–Anscombe correction. Results: ChatGPT-5 received 164 of 189 correct responses (86.8%; 95% CI, 81.2–90.9). Residents’ overall accuracy was 62.9% (713/1,134; 95% CI, 60.0–65.6). The top-performing resident earned 76.7%. ChatGPT-5 outperformed all residents in head-to-head comparisons, with odds ratios ranging from 1.84 (95% CI, 1.10–3.08) to 13.15 (95% CI, 5.93–29.20), all p≤0.023. ChatGPT-5 correctly answered 17/189 items (9.0%), but fewer than half of residents were correct (“large language model-only wins”), whereas residents were more successful on items that ChatGPT-5 overlooked. Conclusions: ChatGPT-5 outperformed ophthalmology residents on text-based glaucoma multiple-choice questions, indicating its potential as a subspecialty education and assessment tool. Generalizability is limited by the single question bank, text-only items, a small resident cohort, and the evaluation of one large language model version at a single time point. Before incorporating these findings into clinical decision-making, larger, multimodal, and longitudinal studies are required.
Amblyopia is a leading, yet largely preventable, cause of visual impairment and is now recognized as a binocular neurodevelopmental disorder characterized by interocular suppression and widespread functional deficits. This narrative review synthesizes contemporary evidence on the epidemiology, pathophysiology, diagnosis, and management of amblyopia, with a focus on clinically applicable guidance. Conventional treatments—including optimal refractive correction, occlusion therapy, and pharmacologic penalization with atropine—remain highly effective when appropriately prescribed, titrated, and monitored for adherence, even among selected older children. Emerging binocular approaches, such as dichoptic digital therapies, perceptual learning, and short-term monocular deprivation, aim to restore binocular balance. Although these strategies may yield improvements in stereopsis and contrast sensitivity, their effects are generally modest and task-specific. Overall, current evidence supports the integration of traditional and novel approaches into etiology-specific, measurement-driven care pathways. Future research should prioritize functional outcomes, long-term durability, and real-world effectiveness.
PURPOSE:The purpose of this study is to look into the relationship between tear film osmolarity, tear crystallization, and corneal esthesiometry findings in Sjögren's syndrome patients. METHODS:This cross-sectional observational study included 43 eyes from patients with a confirmed diagnosis of Sjögren's syndrome. Tear osmolarity was measured with an iPen osmometer, tear crystallization was graded using Roland's classification, and corneal sensitivity was evaluated with a Cochet-Bonnet aesthesiometer. Ocular symptoms were assessed using the Ocular Surface Disease Index questionnaire. Patients who had undergone keratoplasty or worn contact lenses within 4 hours of testing were excluded. RESULTS:The cohort's mean tear osmolarity was 292.5±15.0 mOsm/L (median: 293 mOsm/L, IQR: 17.5). There was no significant difference between patients with primary Sjögren's syndrome (mean: 289.4 mOsm/L) and those with secondary Sjögren's syndrome (mean: 294.5 mOsm/L; p=0.413). Tear crystallization patterns were more severe in patients with primary Sjögren's syndrome (mean: 3.25, median: 3.5, IQR: 1.25) than in those with secondary Sjögren's syndrome (mean: 3.19, median: 3.0, IQR: 1.0), though the difference was not statistically significant (p=0.87). Corneal sensitivity was reduced by 3.5±1.7 mm (median: 4.0 mm, IQR: 2.13). Tear crystallization has a significant negative correlation with corneal sensitivity (r=-0.313, p=0.041), suggesting that poorer tear quality leads to decreased corneal sensitivity. CONCLUSION:Tear crystallization patterns and corneal sensitivity were found to be significantly correlated in Sjögren's syndrome patients. The findings also indicate that systemic medication use may affect tear film quality.
PURPOSE:To compare the efficacy and safety of trabeculectomy with mitomycin C, performed with versus without adjunctive Ologen collagen matrix in a multicenter real-world setting. METHODS:This multicenter retrospective comparative study included 277 patients (365 eyes) who underwent trabeculectomy with mitomycin C, with or without Ologen, between 2017 and 2022 across five Brazilian centers. Extracted data comprised demographic characteristics, glaucoma subtype, intraocular pressure, number of glaucoma medications, postoperative interventions, complications, and additional surgical procedures. Surgical success was defined using two criteria: (1) intraocular pressure ≤21mmHg with ≥20% reduction from baseline and (2) final intraocular pressure between 6 and 21mmHg. Outcomes were categorized as complete (without medications) or qualified (with medications). RESULTS:Both groups achieved substantial reductions in intraocular pressure and medication burden at 12 months, with high rates of complete and qualified success under both definitions. The Ologen group required fewer suture lysis procedures (49.0% vs. 60.8%; p=0.025), suggesting a modulatory effect on early postoperative fibrosis. Rates of other postoperative interventions, complications, and additional glaucoma surgeries were comparable between groups. Kaplan-Meier analysis demonstrated no significant difference in cumulative success over time. CONCLUSION:Trabeculectomy with mitomycin C is effective and safe regardless of adjunctive Ologen use. Although Ologen did not confer superior long-term efficacy, its association with reduced suture lysis suggests a potential role in modulating early wound healing.
PURPOSE:To evaluate the impact of the COVID-19 pandemic and characterize the serological profile of discarded corneal donations in the coverage area of the Banco de Olhos de Londrina, through reverse transcription-polymerase chain reaction testing for COVID-19 and serological screening of cornea donors excluded because of positive test results. METHODS:This observational retrospective study included 776 cornea donors who's serological and reverse transcription-polymerase chain reaction test results were processed at the Hospital of Universidade Estadual de Londrina between May 2020 and 2022. The number of corneal donations and tissue utilization rates throughout the years of operation of the Banco de Olhos de Londrina were also analyzed. RESULTS:The mean donor age was 53.14 years; 332 donors (43%) were female, and 444 (57%) were male. Positive results were identified in 15.76% of donors for hepatitis B core antibody antibodies, 0.65% for hepatitis B surface antigen, 1.03% for hepatitis C antibodies, and 0.52% for human immunodeficiency virus and human T-lymphotropic vírus. Positive reverse transcription-polymerase chain reaction results for SARS-CoV-2 were observed in 2.7% of cases. Older adults were 2.6 times more likely to test positive for SARS-CoV-2 (95% CI, 1.06-6.34) and 3.0 times more likely to test positive for hepatitis B core antibody (95% CI, 1.95-4.41) than younger individuals. A 75.2% reduction in corneal donations was observed in 2020 compared with 2019, accompanied by a 5% increase in tissue utilization, possibly associated with the effectiveness of donor screening during the pandemic. CONCLUSION:The COVID-19 pandemic had a profound impact on the number of corneal transplants worldwide, in Brazil, and at the Banco de Olhos de Londrina because of the substantial decline in donations during this period. Hepatitis B was the leading cause of corneal tissue discard due to positive serology in both this study and previous reports, highlighting the importance of prevention programs and improved vaccination coverage. Strict legislation, comprehensive serological screening, and appropriate processing of donated tissue remain essential to eliminate potential sources of infection and ensure transplantation safety.
